A cluster of broadly neutralizing IgG against BK polyomavirus in a repertoire dominated by IgM

Life Sci Alliance. 2023 Jan 30;6(4):e202201567. doi: 10.26508/lsa.202201567. Print 2023 Apr.

Abstract

The BK polyomavirus (BKPyV) is an opportunistic pathogen, which is only pathogenic in immunosuppressed individuals, such as kidney transplant recipients, in whom BKPyV can cause significant morbidity. To identify broadly neutralizing antibodies against this virus, we used fluorescence-labeled BKPyV virus-like particles to sort BKPyV-specific B cells from the PBMC of KTx recipients, then single-cell RNAseq to obtain paired heavy- and light-chain antibody sequences from 2,106 sorted B cells. The BKPyV-specific repertoire was highly diverse in terms of both V-gene usage and clonotype diversity and included most of the IgM B cells, including many with extensive somatic hypermutation. In two patients where sufficient data were available, IgM B cells in the BKPyV-specific dataset had significant differences in V-gene usage compared with IgG B cells from the same patient. CDR3 sequence-based clustering allowed us to identify and characterize three broadly neutralizing "41F17-like" clonotypes that were predominantly IgG, suggesting that some specific BKPyV capsid epitopes are preferentially targeted by IgG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BK Virus* / genetics
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Kidney Transplantation* / adverse effects
  • Leukocytes, Mononuclear
  • Polyomavirus Infections* / etiology

Substances

  • Immunoglobulin G
  • Immunoglobulin M